A drug ligand based bimetallic coordination-driven self-assembly nanodrug for high-efficiency tumor chemodynamic therapy

Yin-Yin Zhu,Cheng-Jie Huang,Hao Zhong,Qun-Ying Shi,Jin-Mei Lai,Jun-Han Liu,Li-Han Liu
DOI: https://doi.org/10.1016/j.mtchem.2024.101977
IF: 7.613
2024-03-01
Materials Today Chemistry
Abstract:Low chemodynamic catalytic efficiency at weakly acidic microenvironment, inadequate H 2 O 2 and high glutathione (GSH) levels in tumor cells severely limit the efficacy of chemodynamic therapy (CDT). To address these problems, a bimetallic coordination-driven self-assembly nanoparticle named AZC@HA NP is fabricated using the catalase inhibitor 3-amino-1, 2, 4-triazole (3-AT) as the coordination ligands of both copper (II) and zinc (II) ions. Interestingly, parts of Cu 2+ converted into Cu + after coordination. Cu + ions in AZC@HA NPs catalyze the Fenton-like reaction at weakly acidic and neutral microenvironment to produce •OH for CDT. 3-AT elevates intracellular H 2 O 2 level thus augments the •OH generation by inactivating the catalase. AZC@HA NPs decrease intracellular GSH level thus reduce the resistance of tumor cells to CDT through both Cu 2+ -mediated GSH depletion and "Zn 2+ interference" mediated GSH synthesis suppression. Surface coating of hyaluronic acid (HA) allow the targeted accumulation of AZC@HA NPs on CD44 overexpressed tumor cells. The AZC@HA NPs show significantly enhanced tumor inhibition in vitro and in vivo. Overall, the as-prepared tumor targeting, H 2 O 2 elevating and dual GSH exhausting coordination-driven self-assembly nanodrugs AZC@HA NPs provide an innovative strategy for high efficient CDT.
chemistry, multidisciplinary,materials science
What problem does this paper attempt to address?